Impact of Prebiotic β-glucan Treatment at Juvenile Age on the Gut Microbiota Composition and the Eventual Type 1 Diabetes Onset in Non-obese Diabetic Mice is a research paper published in Frontiers in Nutrition (2021). On theSindex it has a DataRank of 0. It has been cited 27 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAID NIH HHS
Grant: R01 AI138511
NIAID NIH HHS
Grant: R21 AI136339
NIAID NIH HHS
Grant: T32 AI132164
NIAID NIH HHS
Grant: R21 AI133798
National Institutes of Health
Grant: 5R21AI136339-02
Contribution of X-linked TLR-Gut microbiota interaction to Juvenile Onset of Systemic Autoimmunity
National Institutes of Health
Grant: 1R21AI133798-01
Contribution of Gut Symbiotic Bacteria to Autoimmunity
National Institutes of Health
Grant: 5R01AI138511-04
Role of microbiota-TLR7/8 Interaction in systemic lupus erythematosus
National Institutes of Health
FWCI
1.33
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of β-glucan protects against necrotizing enterocolitis in mice by inhibiting intestinal inflammation, improving the gut barrier, and modulating gut microbiota
Additional file 1 of β-glucan protects against necrotizing enterocolitis in mice by inhibiting intestinal inflammation, improving the gut barrier, and modulating gut microbiota
Additional file 2 of β-glucan protects against necrotizing enterocolitis in mice by inhibiting intestinal inflammation, improving the gut barrier, and modulating gut microbiota
Additional file 2 of β-glucan protects against necrotizing enterocolitis in mice by inhibiting intestinal inflammation, improving the gut barrier, and modulating gut microbiota